Intraoperative allogeneic blood transfusion is associated with adverse oncological outcomes in patients with surgically treated non-metastatic clear cell renal cell carcinoma.

Ho Won KangSung Pil SeoWon Tae KimSeok Joong YunSang-Cheol LeeWun-Jae KimEu Chang HwangSeok Ho KangSung-Hoo HongJinsoo ChungTae Gyun KwonHyeon Hoe KimCheol KwakSeok-Soo ByunYong-June Kimnull null

Published in: International journal of clinical oncology (2020)

Receipt of a PBT was an independent predictor of RFS and CSS in patients with surgically treated RCC, specifically locally advanced disease. Regarding the prognostic impact of timing or dose of PBT on survival, intraoperative BT and ≥ 3 pRBC units were associated with adverse oncological outcomes.

Keyphrases

rectal cancer
locally advanced
squamous cell carcinoma
stem cell transplantation
small cell lung cancer
radical prostatectomy
patients undergoing
bone marrow
neoadjuvant chemotherapy
radiation therapy
type diabetes
newly diagnosed
lymph node
low dose
adipose tissue
minimally invasive